Genmab | GEN - Dywidenda Wydajność

Cena Akcji
1,729.00
Dzienna Zmiana
7.00 0.41%
Miesięcznie
-0.83%
Rocznie
27.13%
Q2 Prognozy TE
1,604.35




Dy Zmiana Data
Amgen 2.78 0.17 2026-03
argenx SE USD 0 0 2025-03
AstraZeneca USD 1.18 0.56 2026-03
Bayer 0.28 0.02 2026-03
Demant 0 0 2024-12
Fresenius Medical Care 3.86 0.33 2026-03
Genmab 0 0 2025-03
GlaxoSmithKline 0.82 3.75 2026-03
GN Store Nord 0.97 0.19 2022-12
GRIFOLS 2.21 0.29 2026-03
Hikma Pharmaceutical USD 4.02 1.1 2025-12
Lakefront Biotherapeutics 0 0 2025-03
Lonza 0.74 0.04 2025-12
Merck 2.04 0.25 2026-03
Novartis USD 3.33 0.29 2026-03
Regeneron Pharmaceuticals 0.46 0.01 2026-03
Roche Holding 2.96 0.8 2025-12
Sanofi 4.98 0.24 2026-03
UCB 0.58 0.25 2025-12